share_log

Oppenheimer Upgrades Moderna to Outperform, Announces $142 Price Target

Benzinga ·  Jan 2 07:43

Oppenheimer analyst Hartaj Singh upgrades Moderna (NASDAQ:MRNA) from Perform to Outperform and announces $142 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment